Literature DB >> 12968196

Glycoxidation: the menace of diabetes and aging.

Helen Vlassara1, Marcia Rashelle Palace.   

Abstract

Advanced glycation end products (AGE) form via the Maillard reaction in vivo and are also consumed from exogenous sources such as diet and smoking. They alter the structure and function of molecules and increase oxidative stress in biological systems. These consequences promote the pathogenesis of diabetic complications and changes associated with aging, including atherosclerosis, and renal, eye, and neurological disease. Both specific and nonspecific receptor mechanisms mediate these detrimental effects but also participate in the removal and degradation of AGE. AGE toxicity may be averted by promising dietary and pharmacological strategies which are currently being investigated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12968196

Source DB:  PubMed          Journal:  Mt Sinai J Med        ISSN: 0027-2507


  27 in total

1.  Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.

Authors:  Irina G Obrosova; Pal Pacher; Csaba Szabó; Zsuzsanna Zsengeller; Hiroko Hirooka; Martin J Stevens; Mark A Yorek
Journal:  Diabetes       Date:  2005-01       Impact factor: 9.461

Review 2.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

3.  Advanced glycation end products strongly activate platelets.

Authors:  Thomas Gawlowski; Bernd Stratmann; Ruth Ruetter; Christina E Buenting; Barbara Menart; Jürgen Weiss; Helen Vlassara; Theodor Koschinsky; Diethelm Tschoepe
Journal:  Eur J Nutr       Date:  2009-07-26       Impact factor: 5.614

4.  Salivary lysozyme and prevalent hypertension.

Authors:  M Qvarnstrom; S Janket; J A Jones; P Nuutinen; A E Baird; M E Nunn; T E Van Dyke; J H Meurman
Journal:  J Dent Res       Date:  2008-05       Impact factor: 6.116

Review 5.  Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms.

Authors:  Alin Stirban; Thomas Gawlowski; Michael Roden
Journal:  Mol Metab       Date:  2013-12-07       Impact factor: 7.422

Review 6.  [The aging lens--new concepts for lens aging].

Authors:  J Dawczynski; J Strobel
Journal:  Ophthalmologe       Date:  2006-09       Impact factor: 1.059

7.  Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts.

Authors:  I Dineli Bras; Carmen M H Colitz; Donna F Kusewitt; Heather Chandler; Ping Lu; Anne J Gemensky-Metzler; David A Wilkie
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-02       Impact factor: 3.117

8.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

9.  Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation.

Authors:  Franco Folli; Valeria Guzzi; Lucia Perego; Dawn K Coletta; Giovanna Finzi; Claudia Placidi; Stefano La Rosa; Carlo Capella; Carlo Socci; Davide Lauro; Devjit Tripathy; Christopher Jenkinson; Rita Paroni; Elena Orsenigo; Giuliana Cighetti; Luisa Gregorini; Carlo Staudacher; Antonio Secchi; Angela Bachi; Michael Brownlee; Paolo Fiorina
Journal:  PLoS One       Date:  2010-03-29       Impact factor: 3.240

Review 10.  Shifting the disease management paradigm from glucose: what are the pros?

Authors:  Alin Stirban; Diethelm Tschoepe; Bernd Stratmann
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.